Analysts at Deutsche Bank upgrade Amedisys Inc AMED from “hold” to “buy.” The target price for AMED is set to $39.
AMED shares surged 6.29% to close at $29.23 yesterday.
More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
